mutLBSgeneDB |
Gene summary for ABLIM2 |
![]() |
Basic gene Info. | Gene symbol | ABLIM2 |
Gene name | actin binding LIM protein family, member 2 | |
Synonyms | - | |
Cytomap | UCSC genome browser: 4p16.1 | |
Type of gene | protein-coding | |
RefGenes | NM_001130083.1, NM_001130084.1,NM_001130085.1,NM_001130086.1,NM_001130087.1, NM_001130088.1,NM_001286688.1,NM_032432.4, | |
Description | abLIM-2actin binding LIM protein 2actin-binding LIM protein 2actin-binding LIM protein family member 2 | |
Modification date | 20141207 | |
dbXrefs | MIM : 612544 | |
HGNC : HGNC | ||
Ensembl : ENSG00000163995 | ||
Vega : OTTHUMG00000057427 | ||
Protein | UniProt: Q6H8Q1 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_ABLIM2 | |
BioGPS: 84448 | ||
Pathway | NCI Pathway Interaction Database: ABLIM2 | |
KEGG: ABLIM2 | ||
REACTOME: ABLIM2 | ||
Pathway Commons: ABLIM2 | ||
Context | iHOP: ABLIM2 | |
ligand binding site mutation search in PubMed: ABLIM2 | ||
UCL Cancer Institute: ABLIM2 | ||
Assigned class in mutLBSgeneDB | C: This gene just belongs to mutLBSgenes. |
![]() |
GO ID | GO Term | PubMed ID |
Top |
Ligand binding site mutations for ABLIM2 |
![]() |
LBS | AAchange of nsSNV | Cancer type | # samples | C131 | M130L | LUSC | 1 | H103 | P104L | SKCM | 1 | C86 | D87A | STAD | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for ABLIM2 |
![]() Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
![]() ![]() |
![]() |
![]() Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change | C86 | D87A | -1.15768 | H103 | P104L | -0.74143789 | C131 | M130L | -0.52504974 |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
![]() |
Top |
Differential gene expression and gene-gene network for ABLIM2 |
![]() |
![]() |
Top |
Top |
Phenotype information for ABLIM2 |
![]() |
Disease ID | Disease name | # PubMed | Association type |
![]() |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for ABLIM2 |
![]() |
Drug status | DrugBank ID | Name | Type | Drug structure |
![]() |
![]() |
![]() |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS |
Top |
Conservation information for LBS of ABLIM2 |
![]() |
LBS | AA sequence | # species | Species |
![]() |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |